Nano Dimension ADR

Nano Dimension has appointed Moshe Rozenbaum as interim CEO with immediate effect; the board also named Phillip Borenstein as chairman. Rozenbaum, previously vice president of corporate development and a board member, is to work with the board and management to ensure business continuity while strategic priorities are reviewed. Borenstein is a partner and portfolio manager at Hamilton Equity Partners and has served on the board since December 2025. » Más en de.investing.com

Nano Dimension said it is negotiating final terms of a proposed business combination with Infinite Epigenetics and will publish full details once finalized. The company defended Infinite as an operating business with a CLIA-certified methylation lab, existing commercial revenue, a network of over 7,500 healthcare providers, issued IP and a database of 120,000 samples. Nano said the term sheet values Nano at net cash plus a 20% premium, preserves its Nasdaq listing, allows holders to retain contingent value rights on legacy assets and would require a shareholder vote. The deal is framed as a strategic shift from 3D printing toward AI-driven preventive health and diagnostics. » Más en finance.yahoo.com